Detailed stock analysis to assist new CXR/CXRX shareholdersHere is a modified detailed stock analysis by a tool I use. I don't want to plug/promote the tool because it's naive summary of buy. sell and hold isn't that reliable for manipulated stocks like CXR (the shorts killed the stock way below any reasonable stop price!) Its stop price setting was at $62.33 per share so the tool is "confused" right now :-)
I pulled out the good info and posted belot. It's long. Very long. I'll answer question about the tool off-board,, it's easy to fly it wrong but I have no issues with it.
The information below speaks for itself. CXR is easily a $60 stock ($45 USD for CXRX) .
Hope if of use to anyone contemplating looking, or re-buying, Concordia CXR CXRX
.....................
CXR is undervalued compared to its Price of $41.87 per share, has about average safety, ...
Concordia Hlth (CXR)
Drug (Biomedical\Genetic)
Company Information
Business: Concordia Healthcare Corp., formerly Mercari Acquisition Corp., is an integrated, specialty healthcare company focused on the acquisition of pharmaceutical products and medical devices and the acquisition and/or development of orphan drugs. The Company's pharmaceutical business consists of an ADHD-treatment drug, Kapvay(R) (clonidine extended release tablets), a Head Lice Treatment, Ulesfia(R) (benzyl alcohol) Lotion, and an Asthma-related medication, Orapred ODT(R) (prednisolone sodium phosphate orally disintegrating tablets).
Capital Appreciation
Value: Value is a measure of a stock's current worth. CXR has a current Value of $144.68 per share. Therefore, it is undervalued compared to its Price of $41.87 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease. ...At some point in time, a stock's Price and Value always will converge.
RV (Relative Value): RV is an indicator of long-term price appreciation potential. CXR has an RV of 1.82, which is excellent on a scale of 0.00 to 2.00. This indicator is far superior to a simple comparison of Price and Value because it is computed from an analysis of projected price appreciation three years out, AAA Corporate Bond Rates, and risk. RV solves the riddle of whether it is preferable to buy High growth, High P/E stocks, or Low growth, Low P/E stocks. ...purchase ..stocks with RV ratings above 1.00.
RS (Relative Safety): RS is an indicator of risk. CXR has an RS rating of 0.92, which is fair on a scale of 0.00 to 2.00. RS is computed from an analysis of the consistency and predictability of a company's financial performance, debt to equity ratio, sales volume, business longevity, price volatility and other factors. A stock with an RS rating greater than 1.00 is safer and more predictable than the average stock...
GRT (Earnings Growth Rate): GRT reflects a company's one to three year forecasted earnings growth rate in percent per year. CXR has a forecasted Earnings Growth Rate of 50.00%, which [is] excellent. GRT is computed from historical, current and forecasted earnings data. It is updated each week for every stock in the [] database. GRT often foretells a stock's future price trend. If a stock's GRT trend is upward, the stock's price will likely rise. If GRT is trending downward, the stock's Price will probably fall.
EPS (Earnings per Share): EPS stands for leading 12 months Earnings Per Share. CXR has a forecasted EPS of $8.71 per share.
P/E (Price to Earnings Ratio): P/E is a popular measure of stock valuation which shows the dollars required to buy one dollar of earnings. CXR has a P/E of 4.81
Dividend Information
DIV (Dividend): CXR pays an annual dividend of $0.52 per share.
DY (Dividend Yield): DY reflects dividend per share as a percent of Price. CXR has a Dividend Yield of 1.23 %.
DG (Dividend Growth Rate): Dividend Growth is a forecasted annual growth rate of a company's dividend based on historical dividend payments and dividend predictability. It is a subtle yet important indicator of a companys financial performance. It also provides some insight into the boards outlook on the companys ability to increase earnings. CXR has a Dividend Growth of 15%
CI (Comfort Index): CI is an indicator which reflects a stock's ability to resist severe and/or lengthy price declines.CXR has a CI rating of 1.17, which is good on a scale of 0.00 to 2.00.
Sales / Market Capitalization Information
Sales: CXR has annual sales of 334,000,000
Sales Growth: Sales Growth is the Sales Growth Rate in percent over the last 12 months. CXR has a Sales Growth of 198.00% per year. This is excellent. Sales Growth is updated each week
Sales Per Share (SPS): CXR has annual sales of $8.03 per share. SPS can be used as a measure of valuation when comparing stocks within an Industry Group.
Price to Sales Ratio (P/S): CXR has a P/S of 5.22. This ratio is also used as a measure of valuation. Here, too, it is useful when comparing stocks within an Industry Group.
Shares: CXR has 41,000,000 shares of stock outstanding.
Market Capitalization: CXR has a Market Capitalization of $1.75B CDN/ $1.33B USD
.......
Easy take-over target at this price.